4-Hydroxyphenylacetic Acid, a microbial-derived metabolite of Polyphenols, inhibits osteoclastogenesis by inhibiting ROS production
International Immunopharmacology · 2024-12 · 143 · 113571
DOI: 10.1016/j.intimp.2024.113571 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-12. Verfasst von Zhanchi Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, PR China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Osteoclasts, Phenylacetates, Osteogenesis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Hubei Provincial Central Guidance Local Science and Technology Development Project, Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Intracellular reactive oxygen species (ROS) accumulation is key to osteoclast differentiation. Plant-derived polyphenols that have reduced ROS production have been widely studied for the treatment of osteoporosis. However, these compounds are rarely absorbed in the small intestine and are instead converted to phenolic acids by the microbiota in the colon. These large quantities of low-molecular-weight phenolic acids can then be absorbed by the body. 4-Hydroxyphenylacetic acid (4-HPA) is an important metabolite of these polyphenols that is generated by the human intestinal microbiota. However, its potential mechanism is not fully understood. In this study, we aimed to elucidate the role of 4-HPA on osteoclastogenesis and treating osteoporosis. Our study showed that 4-HPA inhibited osteoclast differentiation and function and downregulated osteoclast-specific genes, including NFATc1, Atp6v0d2, MMP9, CTSK, Acp5, and c-Fos. As for further mechanism exploration, 4-HPA reduced ROS accumulation by regulating nuclear factor erythroid 2-related factor (Nrf2) and subsequently inhibited the nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathways. To evaluate the effect of 4-HPA on postmenopausal osteoporosis, an ovariectomized (OVX) mouse model was used. The Micro-CT and histomorphometry analyses showed that 4-HPA effectively prevents bone loss. Encouragingly, 4-HPA demonstrated efficacy in treating osteoporosis induced by OVX. In conclusion, our study revealed that 4-HPA, a polyphenol metabolite produced by intestinal microorganisms, also inhibits osteoclast formation and treats osteoporosis, which provides a new experimental basis and candidate drug for the treatment of osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Anatomy, Hebei Medical University, Shijiazhuang 050017, PR China.
- Department of Orthopaedic Surgery, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, PR China; The Key Laboratory of Orthopedic Biomechanics of Hebei Province, The Third Hospital of Hebei Medical Univ…
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325035, PR China.
- Intensive Care Center, The Fourth Affiliated Hospital of Hebei Medical University, Shijiazhuang 050011, PR China. Electronic address: aj.chen@163.com.
Förderung
- Hubei Provincial Central Guidance Local Science and Technology Development Project
- Natural Science Foundation of Hebei Province
Zitieren
APA
Zhang, Z., Liu, J., Li, Y., Wang, Y., Zheng, X., Wang, F., Tong, T., Miao, D., Li, W., Chen, L., & Wang, L. (2024). 4-Hydroxyphenylacetic Acid, a microbial-derived metabolite of Polyphenols, inhibits osteoclastogenesis by inhibiting ROS production. International Immunopharmacology, 143, 113571. https://doi.org/10.1016/j.intimp.2024.113571
Vancouver
Zhang Z, Liu J, Li Y, Wang Y, Zheng X, Wang F, et al. 4-Hydroxyphenylacetic Acid, a microbial-derived metabolite of Polyphenols, inhibits osteoclastogenesis by inhibiting ROS production. International Immunopharmacology. 2024;143:113571. doi:10.1016/j.intimp.2024.113571
BibTeX
@article{Zhang2024,
author = {Zhang, Zhanchi and Liu, Junchuan and Li, Yijun and Wang, Yunsheng and Zheng, Xiao and Wang, Feng and Tong, Tong and Miao, Dechao and Li, Wenshuai and Chen, Lei and Wang, Linfeng},
title = {4-Hydroxyphenylacetic Acid, a microbial-derived metabolite of Polyphenols, inhibits osteoclastogenesis by inhibiting ROS production},
journal = {International Immunopharmacology},
year = {2024},
volume = {143},
pages = {113571},
doi = {10.1016/j.intimp.2024.113571}
}
EUVIMED